Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis.

Janopaul-Naylor JR, Patil D, Sebastian NT, Salari K, Hershatter B, Gaffney C, Sanda MG, Joshi SS, Patel PR, Jani AB, Patel SA.

Open source

DOI: 10.1016/j.urolonc.2026.08.014
Published: 2026-09-18
Container: Urol Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2026.08.014,
  title = {Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis.},
  author = {Janopaul-Naylor JR and  Patil D and  Sebastian NT and  Salari K and  Hershatter B and  Gaffney C and  Sanda MG and  Joshi SS and  Patel PR and  Jani AB and  Patel SA.},
  year = {2026},
  journal = {Urol Oncol},
  doi = {10.1016/j.urolonc.2026.08.014},
  url = {https://doi.org/10.1016/j.urolonc.2026.08.014}
}

RIS

TY  - JOUR
TI  - Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis.
AU  - Janopaul-Naylor JR
AU  -  Patil D
AU  -  Sebastian NT
AU  -  Salari K
AU  -  Hershatter B
AU  -  Gaffney C
AU  -  Sanda MG
AU  -  Joshi SS
AU  -  Patel PR
AU  -  Jani AB
AU  -  Patel SA.
PY  - 2026
JO  - Urol Oncol
DO  - 10.1016/j.urolonc.2026.08.014
UR  - https://doi.org/10.1016/j.urolonc.2026.08.014
ER  -

APA

JR, J., D, P., NT, S., K, S., B, H., C, G., MG, S., SS, J., PR, P., AB, J., & SA., P. (2026). Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis.. Urol Oncol. https://doi.org/10.1016/j.urolonc.2026.08.014

Source records

europe-pmc · retrieved 2026-09-25T10:28:02.019Z